Delivery Order SPE2DB25D3108-SPE2DB25FPDMY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Vaxneuvance 0.5 ML syringes, valued at $7,899.85. This firm fixed-price delivery order is scheduled for completion by July 22, 2025, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The award was competitively awarded without a set-aside designation, reflecting AmerisourceBergen's capability to meet federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of VAXNEUVANCE 0.5 ML syringes valued at $20,438.65 with a firm fixed price contract type. This order is expected to be completed by July 21, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award was made through a competitive process with no set-aside designation, reflecting AmerisourceBergen's proven capability to meet federal...
- The Defense Logistics Agency awarded a $17,804.46 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Vaxneuvance 0.5 mL syringes. This is a firm fixed price, competitively awarded contract with an ultimate completion date of July 22, 2025, and will be performed in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,647.20 firm fixed-price contract is for the provision of VAXNEUVANCE 0.5 ML syringes, with an ultimate completion date of October 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,358.35 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion pharmaceutical supply vehicle that runs through December 2026. The delivery order is scheduled for completion by July 28, 2025, with performance...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $3,970.80 firm-fixed-price contract is for the supply of 0.5 mL VaxNeuvance syringes, a vaccine product. The contract has an ultimate completion date of August 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, for providing a wide...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,842.45 firm fixed-price delivery order is for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of December 10, 2024. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide VAXNEUVANCE 0.5 ML SYRINGE 0.5ML vaccines. The contract has a ceiling value of $4,885.04 and a period of performance through April 9, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VAXNEUVANCE 0.5 mL syringes. The delivery order has a ceiling value of $6,142.64 and is set to expire on July 19, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. The contract has a ceiling value of $12,972.80 and a period of performance through August 12, 2024. This award is not set aside for any specific business category. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999...
- SPE2DB25D3108Indefinite Delivery Contract
- SPE2DB25D3108-SPE2DB25FPDMYDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 ML syringes, with a contract ceiling value of $2,740.78. The award was issued on July 31, 2025, with an ultimate completion date of August 1, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the contract was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, which is also the location of AmerisourceBergen Drug Corp's corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company supplies a broad range of pharmaceutical products and medical supplies to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle that enables the delivery of specialty medications, vaccines, syringes, and other medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 7/31/25 |